Skip to main content

Malignant Wound Care and Advanced Illness Management

  • Chapter
  • First Online:
Pearls and Pitfalls in Skin Ulcer Management

Abstract

Cancerous wounds or malignant fungating wounds (MFWs) are non-healing chronic painful wounds, that arise in advanced and uncontrolled cancer, as a result of cancerous cells infiltrating cutaneous and subcutaneous tissue, by skin and nonskin cancers. These wounds, due to increased necrosis and infection, and high malodorous discharge, have a detrimental effect on several aspects of the patient’s life in their last few months (Grocott et al. Curr Opin Support Palliat Care. 7(1):101–5, 2013; Furka et al. Cancers. 14(5):1203, 2022).

The incidence of cancer is raising, mainly caused by an ageing population (Weir et al. Cancer. 121(11):1827–37, 2015).

In the meantime, an increase of patients with advanced-stage tumors was registered, probably as a consequence of the delay induced by the restrictions related to public health containment measures for the SARS-CoV-2 infection and managing a chronic disease in such a setting, may result extremely demanding (Lo et al. J Clin Nurs. 17(20):2699–708, 2008).

The treatment of cutaneous tumors, regardless of their histological origin, usually requires a surgical approach, considered being the most effective when applicable. However, due to the severity and debilitating nature of MFWs, surgery might not be always considered a feasible option, and managing these wounds requires integrated palliative care until death. According to the World Health Organization, palliative care is an “approach that improves the quality of life of patients (adults and children) and their families who are facing problems associated with life-threatening illness. It prevents and relieves suffering through the early identification, correct assessment and treatment of pain and other problems, whether physical, psychosocial or spiritual” (Palliative care. https://www.who.int/news-room/fact-sheets/detail/palliative-care). Nowadays, a multidisciplinary approach to cancerous wound treatment is mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grocott P, Gethin G, Probst S. Malignant wound management in advanced illness: new insights. Curr Opin Support Palliat Care. 2013;7(1):101–5. https://doi.org/10.1097/SPC.0b013e32835c0482.

    Article  PubMed  Google Scholar 

  2. Furka A, Simkó C, Kostyál L, et al. Treatment algorithm for cancerous wounds: a systematic review. Cancers. 2022;14(5):1203. https://doi.org/10.3390/cancers14051203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121(11):1827–37. https://doi.org/10.1002/cncr.29258.

    Article  PubMed  Google Scholar 

  4. Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY. Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs. 2008;17(20):2699–708. https://doi.org/10.1111/j.1365-2702.2008.02482.x.

    Article  PubMed  Google Scholar 

  5. Marcasciano M, Kaciulyte J, Mori FLR, Lo Torto F, Ribuffo D, Casella D. Plastic surgery in the time of coronavirus in Italy. Maybe we should say: “thanks Darwin we are plastic surgeons!”. J Plast Reconstr Aesthet Surg. 2021;74(7):1633–701. https://doi.org/10.1016/j.bjps.2021.01.010.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ramasubbu DA, Smith V, Hayden F, Cronin P. Systemic antibiotics for treating malignant wounds. Cochrane Database Syst Rev. 2017;8:CD011609. https://doi.org/10.1002/14651858.CD011609.pub2.

    Article  PubMed  Google Scholar 

  7. Vardhan M, Flaminio Z, Sapru S, et al. The microbiome, malignant fungating wounds, and palliative care. Front Cell Infect Microbiol. 2019;9:373. https://doi.org/10.3389/fcimb.2019.00373; Accessed 3 Jul 2022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006;22(3):185–93. https://doi.org/10.1016/j.soncn.2006.04.006.

    Article  PubMed  Google Scholar 

  9. Fromantin I, Seyer D, Watson S, et al. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368–73. https://doi.org/10.1128/JCM.01277-13.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci Biotechnol Biochem. 2009;73(9):2117–20. https://doi.org/10.1271/bbb.90229.

    Article  CAS  PubMed  Google Scholar 

  11. Palliative care. https://www.who.int/news-room/fact-sheets/detail/palliative-care. Accessed 10 Jul 2022.

  12. Common terminology criteria for adverse events (CTCAE). Published online 2017:155.

    Google Scholar 

  13. RECIST. https://recist.eortc.org/. Accessed 10 Jul 2022.

  14. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res. 2011;63(Suppl 11):S240–52. https://doi.org/10.1002/acr.20543.

    Article  Google Scholar 

  15. Developing a tool for researching fungating wounds. http://www.worldwidewounds.com/2001/july/Grocott/Fungating-Wounds.html. Accessed 10 Jul 2022.

  16. Williams GR, Manjunath SH, Butala AA, Jones JA. Palliative radiotherapy for advanced cancers: indications and outcomes. Surg Oncol Clin N Am. 2021;30(3):563–80. https://doi.org/10.1016/j.soc.2021.02.007.

    Article  PubMed  Google Scholar 

  17. Kakavand H, Wilmott JS, Long GV, Scolyer RA. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists. Pathology (Phila). 2016;48(2):194–202. https://doi.org/10.1016/j.pathol.2015.12.010.

    Article  CAS  Google Scholar 

  18. Jiang T, Zhou C. The past, present and future of immunotherapy against tumor. Transl Lung Cancer Res. 2015;4(3):253–64. https://doi.org/10.3978/j.issn.2218-6751.2015.01.06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Alexander S. Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. J Wound Care. 2009;18(7):273–4. https://doi.org/10.12968/jowc.2009.18.7.43110; 276–278, 280.

    Article  CAS  PubMed  Google Scholar 

  20. O’Neill L, Nelson Z, Ahmad N, et al. Malignant fungating wounds of the head and neck: management and antibiotic stewardship. OTO Open. 2022;6(1):2473974X211073306. https://doi.org/10.1177/2473974X211073306.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Goto H, Omodaka T, Yanagisawa H, et al. Palliative surgical treatment for cutaneous metastatic tumor is a valid option for improvement of quality of life. J Dermatol. 2016;43(1):95–8. https://doi.org/10.1111/1346-8138.12983.

    Article  PubMed  Google Scholar 

  22. Miner TJ, Brennan MF, Jaques DP. A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg. 2004;240(4):719–26. https://doi.org/10.1097/01.sla.0000141707.09312.dd; discussion 726–727.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rankin T, Mailey B, Suliman A, Dobke M. Palliative reconstructive surgery may improve quality of life in high functioning noncurable head and neck oncologic patients. Ann Plast Surg. 2015;74(Suppl 1):S52–6. https://doi.org/10.1097/SAP.0000000000000498.

    Article  CAS  PubMed  Google Scholar 

  24. Fioramonti P, Sorvillo V, Maruccia M, et al. New application of purse string suture in skin cancer surgery. Int Wound J. 2018;15(6):893–9. https://doi.org/10.1111/iwj.12941.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ribuffo D, Berna G, De Vita R, et al. Dual-plane retro-pectoral versus pre-pectoral DTI breast reconstruction: an Italian multicenter experience. Aesthet Plast Surg. 2021;45(1):51–60. https://doi.org/10.1007/s00266-020-01892-y.

    Article  Google Scholar 

  26. Dai C, Shih S, Khachemoune A. Skin substitutes for acute and chronic wound healing: an updated review. J Dermatol Treat. 2020;31(6):639–48. https://doi.org/10.1080/09546634.2018.1530443.

    Article  CAS  Google Scholar 

  27. Dessy LA, Marcasciano M, Fanelli B, Mazzocchi M, Ribuffo D. Surgical treatment of nasal non-melanoma skin cancer in elderly patients using dermal substitute. Acta Otolaryngol. 2016;136(12):1299–303. https://doi.org/10.1080/00016489.2016.1205221.

    Article  CAS  PubMed  Google Scholar 

  28. Marcasciano M, Mazzocchi M, Kaciulyte J, et al. Skin cancers and dermal substitutes: is it safe? Review of the literature and presentation of a 2-stage surgical protocol for the treatment of non-melanoma skin cancers of the head in fragile patients. Int Wound J. 2018;15(5):756–68. https://doi.org/10.1111/iwj.12924.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Marcasciano M, Kaciulyte J, Di Giuli R, et al. Electrochemotherapy: first objective quality assessment of online information on a rising low-invasive procedure, in a constantly aging society. Eur J Plast Surg doi:https://doi.org/10.1007/s00238-021-01921-2; Published online January 27, 2022.

  30. Guida M, Campana LG, Curatolo P, et al. Local treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study. J Surg Oncol. 2016;114(2):246–53. https://doi.org/10.1002/jso.24287.

    Article  PubMed  Google Scholar 

  31. Gehl J, Sersa G, Matthiessen LW, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 2018;57(7):874–82. https://doi.org/10.1080/0284186X.2018.1454602.

    Article  PubMed  Google Scholar 

  32. Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol. 2013;39(1):4–16. https://doi.org/10.1016/j.ejso.2012.08.016.

    Article  CAS  PubMed  Google Scholar 

  33. Mali B, Miklavcic D, Campana LG, et al. Tumor size and effectiveness of electrochemotherapy. Radiol Oncol. 2013;47(1):32–41. https://doi.org/10.2478/raon-2013-0002.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Morley J, Grocott P, Purssell E, Murrells T. Electrochemotherapy for the palliative management of cutaneous metastases: a systematic review and meta-analysis. Eur J Surg Oncol. 2019;45(12):2257–67. https://doi.org/10.1016/j.ejso.2019.07.003.

    Article  PubMed  Google Scholar 

  35. Adderley UJ, Holt IGS. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014;5:CD003948. https://doi.org/10.1002/14651858.CD003948.pub3.

    Article  Google Scholar 

  36. Kalemikerakis J, Vardaki Z, Fouka G, et al. Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds. J BUON. 2012;17(3):560–4.

    CAS  PubMed  Google Scholar 

  37. Tsichlakidou A, Govina O, Vasilopoulos G, Kavga A, Vastardi M, Kalemikerakis I. Intervention for symptom management in patients with malignant fungating wounds—a systematic review. J BUON. 2019;24(3):1301–8.

    PubMed  Google Scholar 

  38. Villela-Castro DL, de VLCG S, Woo K. Polyhexanide versus metronidazole for odor management in malignant (fungating) wounds: a double-blinded, randomized, clinical trial. J Wound Ostomy Continence Nurs. 2018;45(5):413–8. https://doi.org/10.1097/WON.0000000000000460.

    Article  PubMed  Google Scholar 

  39. Kratz A, Danon A. Controlling bleeding from superficial wounds by the use of topical alpha adrenoreceptor agonists spray. A randomized, masked, controlled study. Injury. 2004;35(11):1096–101. https://doi.org/10.1016/j.injury.2004.03.015.

    Article  PubMed  Google Scholar 

  40. Casella D, Palumbo P, Sandroni S, et al. Positive ROS (reactive oxygen species) modulator engineered device support skin treatment in locally advanced breast cancer (LABC) enhancing patient quality of life. J Clin Med. 2021;11(1):126. https://doi.org/10.3390/jcm11010126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Apelqvist J, Willy C, Fagerdahl AM, et al. EWMA document: negative pressure wound therapy. J Wound Care. 2017;26(Sup3):S1–S154. https://doi.org/10.12968/jowc.2017.26.Sup3.S1.

    Article  PubMed  Google Scholar 

  42. Marcasciano M, Cavalieri E, Kaciulyte J, et al. Temporary, customized negative pressure wound therapy to assist wound closure in selected patients: a practical solution or a bridge to advanced care. Wound Repair Regen. 2019;27(6):720–1. https://doi.org/10.1111/wrr.12755.

    Article  PubMed  Google Scholar 

  43. Maruccia M, Onesti MG, Sorvillo V, et al. An alternative treatment strategy for complicated chronic wounds: negative pressure therapy over mesh skin graft. Biomed Res Int. 2017;2017:8395219. https://doi.org/10.1155/2017/8395219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Riot S, de Bonnecaze G, Garrido I, Ferron G, Grolleau JL, Chaput B. Is the use of negative pressure wound therapy for a malignant wound legitimate in a palliative context? “The concept of NPWT ad vitam”: a case series. Palliat Med. 2015;29(5):470–3. https://doi.org/10.1177/0269216314560009.

    Article  PubMed  Google Scholar 

  45. Price P, Fogh K, Glynn C, Krasner DL, Osterbrink J, Sibbald RG. Managing painful chronic wounds: the wound pain management model. Int Wound J. 2007;4(Suppl 1):4–15. https://doi.org/10.1111/j.1742-481X.2007.00311.x.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Schaible HG, Richter F. Pathophysiology of pain. Langenbeck’s Arch Surg. 2004;389(4):237–43. https://doi.org/10.1007/s00423-004-0468-9.

    Article  Google Scholar 

  47. Briggs M, Nelson EA, Martyn-St JM. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev. 2012;11:CD001177. https://doi.org/10.1002/14651858.CD001177.pub3.

    Article  PubMed  Google Scholar 

  48. Di Stefano G, Di Lionardo A, Di Pietro G, Cruccu G, Truini A. Pharmacotherapeutic options for managing neuropathic pain: a systematic review and meta-analysis. Pain Res Manag. 2021;2021:6656863. https://doi.org/10.1155/2021/6656863.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marcasciano, M., Nanni, J., Greto Ciriaco, A., Fiorillo, M.A., Casella, D., Greco, M. (2023). Malignant Wound Care and Advanced Illness Management. In: Maruccia, M., Papa, G., Ricci, E., Giudice, G. (eds) Pearls and Pitfalls in Skin Ulcer Management. Springer, Cham. https://doi.org/10.1007/978-3-031-45453-0_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-45453-0_50

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-45452-3

  • Online ISBN: 978-3-031-45453-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics